Cargando…
Upregulation of CDGSH iron sulfur domain 2 attenuates cerebral ischemia/reperfusion injury
CDGSH iron sulfur domain 2 can inhibit ferroptosis, which has been associated with cerebral ischemia/reperfusion, in individuals with head and neck cancer. Therefore, CDGSH iron sulfur domain 2 may be implicated in cerebral ischemia/reperfusion injury. To validate this hypothesis in the present stud...
Autores principales: | Hu, Miao, Huang, Jie, Chen, Lei, Sun, Xiao-Rong, Yao, Zi-Meng, Tong, Xu-Hui, Jin, Wen-Jing, Zhang, Yu-Xin, Dong, Shu-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075131/ https://www.ncbi.nlm.nih.gov/pubmed/36571356 http://dx.doi.org/10.4103/1673-5374.355766 |
Ejemplares similares
-
Structure and Molecular Evolution of CDGSH Iron-Sulfur Domains
por: Lin, Jinzhong, et al.
Publicado: (2011) -
Phylogenetic analysis of the CDGSH iron-sulfur binding domain reveals its ancient origin
por: Sengupta, Soham, et al.
Publicado: (2018) -
The NFκB Antagonist CDGSH Iron-Sulfur Domain 2 Is a Promising Target for the Treatment of Neurodegenerative Diseases
por: Kung, Woon-Man, et al.
Publicado: (2021) -
Anti-Inflammatory CDGSH Iron-Sulfur Domain 2: A Biomarker of Central Nervous System Insult in Cellular, Animal Models and Patients
por: Kung, Woon-Man, et al.
Publicado: (2022) -
A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinoma
por: Yang, Lin, et al.
Publicado: (2016)